Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases
Abnormal aggregation and accumulation of pathological amyloid proteins such as amyloid-β, Tau, and α-synuclein play key pathological roles and serve as histological hallmarks in different neurodegenerative diseases (NDs) such as Alzheimer's disease (AD) and Parkinson's disease (PD). In add...
Main Authors: | Shenqing Zhang, Hui Dong, Jiang Bian, Dan Li, Cong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co. Ltd.
2023-07-01
|
Series: | Fundamental Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667325822004228 |
Similar Items
-
From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias
by: Adalberto Studart-Neto, et al.
Published: (2022-08-01) -
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact
by: Lyduine E. Collij, et al.
Published: (2023-01-01) -
Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
by: Min Seok Baek, et al.
Published: (2020-10-01) -
Synergistic interaction of high blood pressure and cerebral beta-amyloid on tau pathology
by: Taewon Kim, et al.
Published: (2022-12-01) -
Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET
by: Joanna L. Shuping, et al.
Published: (2023-01-01)